Boothbay Fund Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,632
Closed -$182K 2083
2025
Q4
$182K Hold
12,632
﹤0.01% 1681
2025
Q3
$201K Buy
+12,632
New +$208K ﹤0.01% 1641

Other funds holding BTAL

Boothbay Fund Management's BTAL Position: Q1 2026 in Review

Boothbay Fund Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2026, closing a stake of 12,632 shares — an estimated $182K sold.

Boothbay Fund Management first reported a position in BTAL in Q3 2025 and held it in 2 quarters. The position peaked at $201K in Q3 2025. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Boothbay Fund Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 12,632 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $182K.
  • Boothbay Fund Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and held it in 2 quarters.
  • Boothbay Fund Management's AGF US Market Neutral Anti-Beta Fund position peaked at $201K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.